Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levetiracetam as adjunctive therapy for generalized tonic-clonic seizures (China Phase III)
CTR20131703Phase 3Active
- Sponsor
- UCB
- Start
- Sep 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of levetiracetam in Epilepsy with generalized tonic-clonic seizures (GTCS), sponsored by UCB. Started Sep 2014; status: active.
02
Drugs
levetiracetam
03
Conditions
Epilepsy with generalized tonic-clonic seizures (GTCS)
Beyond the preview
Go deeper on CTR20131703.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20131703.